Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10,946 GBX | +0.29% | -1.07% | +3.26% |
Apr. 17 | AstraZeneca: presents new data at ECCMID | CF |
Apr. 17 | The market is pinning its hopes on earnings reports |
Financials (USD)
Sales 2024 * | 50.77B | Sales 2025 * | 54.26B | Capitalization | 211B |
---|---|---|---|---|---|
Net income 2024 * | 8.74B | Net income 2025 * | 10.24B | EV / Sales 2024 * | 4.54 x |
Net Debt 2024 * | 19.66B | Net Debt 2025 * | 12.86B | EV / Sales 2025 * | 4.12 x |
P/E ratio 2024 * |
24.6
x | P/E ratio 2025 * |
20.9
x | Employees | 89,900 |
Yield 2024 * |
2.28% | Yield 2025 * |
2.4% | Free-Float | 96.44% |
Latest transcript on AstraZeneca PLC
1 day | +0.29% | ||
1 week | -0.15% | ||
Current month | +2.51% | ||
1 month | +6.38% | ||
3 months | +4.93% | ||
6 months | +3.15% | ||
Current year | +3.26% |
Managers | Title | Age | Since |
---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 63 | 12-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 50 | 21-07-31 |
Cindy Hoots
CTO | Chief Tech/Sci/R&D Officer | 56 | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sherilyn McCoy
BRD | Director/Board Member | 65 | 17-09-30 |
Ahmed Hamdy
PRN | Corporate Officer/Principal | 59 | 13-01-31 |
Philip Broadley
BRD | Director/Board Member | 63 | 17-04-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
9.20% | 11 M€ | +0.83% | - | |
5.39% | 192 M€ | +11.13% | ||
5.17% | 18 M€ | +1.40% | - | |
4.89% | 776 M€ | +6.35% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 10,946 | +0.29% | 1,221,642 |
24-04-18 | 10,914 | +0.48% | 2,446,630 |
24-04-17 | 10,862 | -0.15% | 2,243,525 |
24-04-16 | 10,878 | -1.32% | 1,318,970 |
24-04-15 | 11,024 | -0.36% | 1,392,030 |
Delayed Quote London S.E., April 19, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.26% | 211B | |
+24.60% | 672B | |
+24.08% | 550B | |
-5.63% | 351B | |
+15.37% | 317B | |
+7.38% | 292B | |
+0.78% | 203B | |
-9.69% | 144B | |
-6.63% | 141B | |
-3.20% | 113B |
- Stock Market
- Equities
- AZN Stock